📰 Abt News
Page 32 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
February 2, 2024
Oppenheimer & Co. Inc. increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 106,641 shares of the healthcare product maker’s stock after acquiring an additional 7,013 shares during the […]
February 2, 2024
Kestra Private Wealth Services LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.3% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 101,652 shares of the healthcare product maker’s stock after acquiring an additional 9,470 […]
February 2, 2024
Valmark Advisers Inc. lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 15,521 shares of the healthcare product maker’s stock after buying an additional 236 shares during the quarter. Valmark Advisers Inc.’s holdings in Abbott Laboratories were worth $1,503,000 at […]
February 2, 2024
Fidelis Capital Partners LLC raised its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.2% in the 3rd quarter, Holdings Channel reports. The firm owned 14,594 shares of the healthcare product maker’s stock after purchasing an additional 317 shares during the quarter. Fidelis Capital Partners LLC’s holdings in Abbott Laboratories were worth […]
February 2, 2024
Arcblock (ABT) traded 5.2% lower against the U.S. dollar during the 24-hour period ending at 16:00 PM ET on February 2nd. Over the last week, Arcblock has traded up 37.3% against the U.S. dollar. Arcblock has a market capitalization of $33.80 million and approximately $1.81 million worth of Arcblock was traded on exchanges in the […]
February 1, 2024
Prosperity Financial Group Inc. lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,431 shares of the healthcare product maker’s stock after acquiring an additional 144 shares […]
February 1, 2024
Arcblock (ABT) traded 13.8% lower against the U.S. dollar during the 1-day period ending at 22:00 PM Eastern on January 31st. Arcblock has a market capitalization of $34.61 million and approximately $7.11 million worth of Arcblock was traded on exchanges in the last day. During the last seven days, Arcblock has traded up 53.2% against […]
February 1, 2024
Merit Financial Group LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,892 shares of the healthcare product maker’s stock after buying an additional 1,470 […]
February 1, 2024
Motco raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 12.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,072 shares of the healthcare product maker’s stock after buying an additional 119 shares during the quarter. Motco’s holdings in Abbott Laboratories […]
February 1, 2024
Oppenheimer Asset Management Inc. lowered its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 19.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 199,220 shares of the healthcare product maker’s stock after selling 47,694 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings […]